ZA200709252B - N-alkylcarbonyl-amino acid ester and n-alkylcarbonyl-amino lactone compounds and their use - Google Patents

N-alkylcarbonyl-amino acid ester and n-alkylcarbonyl-amino lactone compounds and their use

Info

Publication number
ZA200709252B
ZA200709252B ZA200709252A ZA200709252A ZA200709252B ZA 200709252 B ZA200709252 B ZA 200709252B ZA 200709252 A ZA200709252 A ZA 200709252A ZA 200709252 A ZA200709252 A ZA 200709252A ZA 200709252 B ZA200709252 B ZA 200709252B
Authority
ZA
South Africa
Prior art keywords
alkylcarbonyl
amino
acid ester
amino acid
lactone compounds
Prior art date
Application number
ZA200709252A
Other languages
English (en)
Inventor
Edward Tak Wei
Original Assignee
Edward Tak Wei
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Edward Tak Wei filed Critical Edward Tak Wei
Publication of ZA200709252B publication Critical patent/ZA200709252B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/26—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D307/30—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/32—Oxygen atoms
    • C07D307/33—Oxygen atoms in position 2, the oxygen atom being in its keto or unsubstituted enol form
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/02—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having nitrogen atoms of carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals
    • C07C233/04—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having nitrogen atoms of carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals with carbon atoms of carboxamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
    • C07C233/05—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having nitrogen atoms of carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals with carbon atoms of carboxamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/14—Antitussive agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/34—Tobacco-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/02—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having nitrogen atoms of carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals
    • C07C233/08—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having nitrogen atoms of carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals with carbon atoms of carboxamide groups bound to acyclic carbon atoms of a saturated carbon skeleton containing rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/57—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of rings other than six-membered aromatic rings
    • C07C233/63—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of rings other than six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C243/00—Compounds containing chains of nitrogen atoms singly-bound to each other, e.g. hydrazines, triazanes
    • C07C243/24—Hydrazines having nitrogen atoms of hydrazine groups acylated by carboxylic acids
    • C07C243/38—Hydrazines having nitrogen atoms of hydrazine groups acylated by carboxylic acids with acylating carboxyl groups bound to carbon atoms of six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • C07C255/49—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C255/57—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing cyano groups and carboxyl groups, other than cyano groups, bound to the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/86—Hydrazides; Thio or imino analogues thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D277/24—Radicals substituted by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/68—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/82—Benzo [b] furans; Hydrogenated benzo [b] furans with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
    • C07D307/84—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/82—Benzo [b] furans; Hydrogenated benzo [b] furans with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
    • C07D307/84—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D307/85—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/38—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07—Optical isomers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14—The ring being saturated

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Dermatology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Addiction (AREA)
  • Rheumatology (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Pain & Pain Management (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyrane Compounds (AREA)
ZA200709252A 2005-03-29 2006-03-23 N-alkylcarbonyl-amino acid ester and n-alkylcarbonyl-amino lactone compounds and their use ZA200709252B (en)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US66716605P 2005-03-29 2005-03-29
US68338405P 2005-05-20 2005-05-20
US70250505P 2005-07-25 2005-07-25
US20372805A 2005-08-13 2005-08-13
US77237406P 2006-02-09 2006-02-09
PCT/GB2006/001093 WO2006103401A2 (en) 2005-03-29 2006-03-23 N-alkylcarbonyl-amino acid ester and n-alkylcarbonyl-amino lactone compounds and their use

Publications (1)

Publication Number Publication Date
ZA200709252B true ZA200709252B (en) 2009-04-29

Family

ID=36498694

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200709252A ZA200709252B (en) 2005-03-29 2006-03-23 N-alkylcarbonyl-amino acid ester and n-alkylcarbonyl-amino lactone compounds and their use

Country Status (19)

Country Link
US (2) US20110082204A1 (enExample)
EP (2) EP1871738B1 (enExample)
JP (2) JP2008538115A (enExample)
KR (1) KR20070116133A (enExample)
CN (1) CN101184725B (enExample)
AU (1) AU2006228280B2 (enExample)
BR (1) BRPI0609784C1 (enExample)
CA (1) CA2602075C (enExample)
CY (1) CY1109420T1 (enExample)
DE (1) DE602006007831D1 (enExample)
DK (1) DK1871738T3 (enExample)
ES (1) ES2328847T3 (enExample)
IL (1) IL186297A0 (enExample)
MX (1) MX2007011831A (enExample)
PL (1) PL1871738T3 (enExample)
PT (1) PT1871738E (enExample)
SI (1) SI1871738T1 (enExample)
WO (1) WO2006103401A2 (enExample)
ZA (1) ZA200709252B (enExample)

Families Citing this family (64)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102027176B1 (ko) * 2005-03-29 2019-10-01 악살비온 에스아 〔（（1ｒ,2ｓ,5ｒ）―2―이소프로필―5―메틸―시클로헥산카르보닐）―아미노〕―아세트산 이소프로필 에스테르와 관련 화합물 및 요법에서 그의 용도
WO2012076831A1 (en) * 2010-12-06 2012-06-14 Paget, Hugh, Charles, Edward [((1r,2s,5r)-2-isopropyl-5-methyl-cyclohexanecarbonyl)-amino]-acetic acid isopropyl ester and related compounds and their use in therapy
DE102006047162A1 (de) * 2006-09-29 2008-04-03 Beiersdorf Ag Kosmetische oder dermatologische Zubereitungen mit Kombinationen aus (R)-2-[((1R,2S,5R)-2-isopropyl-5-methyl-cyclohexanecarbonyl)-amino]-propionsäure methyl ester und einer oder mehreren Lichtschutzfiltersubstanzen
DE102006047164A1 (de) * 2006-09-29 2008-04-03 Beiersdorf Ag Kosmetische oder dermatologische Zubereitungen mit einem Gehalt an 2-Isopropyl-5-Methyl-Cyclohexancarbonyl-D-Alaninmethylester und einem oder mehreren Hautbefeuchtungsmitteln
EP1913976A1 (de) * 2006-10-18 2008-04-23 Symrise GmbH & Co. KG N-alpha-(Menthancarbonyl)aminosäureamide und deren Verwendung als physiologische Kühlwirkstoffe
EP2079681B1 (en) * 2006-11-08 2010-09-15 Edward T. Wei N-alkylcarbonyl-d-amino hydroxyalkyl ester compounds and their use
EP2014333A1 (en) * 2007-07-12 2009-01-14 Hakiman Shargh Research Company Use of cooling agents for treatment or prevention of lacrimation or eye burning
GB2451503B (en) * 2007-08-01 2011-10-12 Lrc Products Stimulating gel comprising a cyclic carboxamide coolant
WO2009081107A1 (en) * 2007-12-21 2009-07-02 Paget, Hugh, Charles, Edward P-menthawe-3-carboxylic acid esters to treat airways diseases
DE102008015424A1 (de) * 2008-03-20 2009-09-24 Beiersdorf Ag Kühlende kosmetische oder dermatologische Zubereitungen mit einem Gehalt an (1R,2S,5R)-2-Isopropyl-5-methyl-N-(2-(pyridyn-2-yl)ethyl-cyclohexancarboxamid und/oder (1R,2S,5R)-N-(4-(Cyanomethyl)-phenyl)-2-isopropyl-5- methylcyclohexancarboxamid mit Menthoxypropandiol
DE102008015426A1 (de) * 2008-03-20 2009-09-24 Beiersdorf Ag Kühlende kosmetische oder dermatologische Zubereitungen mit einem Gehalt an (1R,2S,5R)-2-Isopropyl-5-methyl-N-(2-(pyridyn-2-yl)ethyl-cyclohexancarboxamid und/oder (1R,2S,5R)-N-(4-(Cyanomethyl)-phenyl)-2-isopropyl-5-methylcyclohexancarboxamid zu Reduktion von Hautrötungen
EP2318356B1 (en) 2008-08-15 2015-03-11 The Procter & Gamble Company Synthesis of cyclohexane derivatives useful as sensates in consumer products
EP2313070A1 (en) 2008-08-15 2011-04-27 The Procter & Gamble Company Solution of menthane carboxamides for use in consumer products
ES2626230T3 (es) 2008-11-20 2017-07-24 The Procter & Gamble Company Composiciones para la higiene personal que proporcionan una sensación refrescante mejorada
WO2010139954A1 (en) * 2009-06-05 2010-12-09 Wei Edward Tak Treatment of eye discomfort by topical administration of a cooling agent to the external surface of the eyelid
US9446267B2 (en) 2009-10-06 2016-09-20 Symrise Ag Products comprising a flavoring agent composition
EP2186506B1 (de) 2009-10-06 2015-09-30 Symrise AG Mentholhaltige Zahnputz-Zusammensetzung mit reduzierter Bitterwahrnehmung
US20120014883A1 (en) 2010-07-19 2012-01-19 Douglas Craig Scott Compositions Comprising Derivatives Of Essential Oil Compounds And Use In Personal Care Products
EP2621462B1 (en) 2010-10-01 2020-02-12 The Procter and Gamble Company Oral care compositions with improved flavor
CA2824827A1 (en) 2011-01-18 2012-07-26 Edward Tak Wei (r)-1,2-propanediol for use as a solvent in therapeutic cooling agent compositions
US8426463B2 (en) * 2011-04-04 2013-04-23 Edward T. Wei [((1R,2S,5R)-2-isopropyl-5-methyl-cyclohexanecarbonyl)-amino]-acetic acid isopropyl ester and related compounds and their use in therapy
US20130042482A1 (en) 2011-08-16 2013-02-21 Valerie Jean Bradford Skin Engaging Member Comprising An Anti-Irritation Agent
CA2847249C (en) 2011-09-01 2016-10-18 The Procter & Gamble Company Oral care compositions with improved rheology
CN104159580A (zh) * 2011-12-21 2014-11-19 Wm.雷格利Jr.公司 含有[(2-异丙基-5-甲基-环己烷羰基)-氨基]-乙酸异丙酯的口香糖产品
US20130315843A1 (en) 2012-05-25 2013-11-28 The Procter & Gamble Company Composition for reduction of trpa1 and trpv1 sensations
KR20150050566A (ko) 2012-09-28 2015-05-08 더 질레트 컴퍼니 하나 이상의 열탄성 센세이트를 포함하는 피부 맞닿음 면도 보조 부재
IN2015DN01440A (enExample) 2012-09-28 2015-07-03 Gillette Co
US9265458B2 (en) 2012-12-04 2016-02-23 Sync-Think, Inc. Application of smooth pursuit cognitive testing paradigms to clinical drug development
US9380976B2 (en) 2013-03-11 2016-07-05 Sync-Think, Inc. Optical neuroinformatics
CA2959231C (en) 2013-10-22 2022-06-21 Edward Tak Wei Di-isopropyl-phosphinoyl-alkane (dapa) compounds as topical agents for the treatment of sensory discomfort
JP2016535027A (ja) 2013-10-22 2016-11-10 エドワード タク ウェイＷＥＩ， Ｅｄｗａｒｄ Ｔａｋ 非角化重層上皮（ＮＫＳＥ）組織の不快感の治療用局所薬としての１−ジ（ｓｅｃ−ブチル）−ホスフィノイル−ペンタン（ＤＡＰＡ−２−５）
US9884130B2 (en) 2013-11-13 2018-02-06 The Procter & Gamble Company Compositions for delivery of oral comfort sensations
EP3110510A1 (en) 2014-02-27 2017-01-04 The Procter & Gamble Company Oral care compositions with a reduced bitter taste perception
US20150272847A1 (en) 2014-03-26 2015-10-01 The Gillette Company Skin Engaging Shaving Aid Comprising A Thermally Resilient Sensate And A TRPA1 Receptor Inhibitor
US20150273711A1 (en) 2014-03-26 2015-10-01 The Gillette Company Razor Comprising A Molded Shaving Aid Composition Comprising A Thermally Resilient Sensate
MX2016013618A (es) 2014-04-23 2017-02-28 Procter & Gamble Ciclohexanocarboxamida con propiedades de enfriamiento.
MX2017002099A (es) 2014-08-15 2017-05-04 Procter & Gamble Composiciones para el cuidado bucal con una experiencia sensorial mejorada.
CA2956966C (en) 2014-08-15 2020-08-11 The Procter & Gamble Company Dentifrice with incremental chemistries
AU2015301965B2 (en) 2014-08-15 2018-10-04 The Procter & Gamble Company Oral care compositions and regimens
MX2017006347A (es) 2014-11-26 2017-08-21 Gillette Co Llc Un miembro de acoplamiento con la piel que comprende acetato de etilenvinilo.
US9951295B2 (en) 2015-02-19 2018-04-24 The Procter & Gamble Company Compositions for deposition on biological surfaces
AU2016245865B2 (en) 2015-04-09 2019-04-11 The Procter & Gamble Company Reduction in CPC taste aversion by reducing CPC activation of TRPA1 receptors, TPRV1 receptors, or both
WO2017004437A1 (en) * 2015-06-30 2017-01-05 Wm. Wrigley Jr. Company Long-lasting cooling formulations
BR112018006563B1 (pt) 2015-10-22 2022-05-10 The Procter & Gamble Company Método para preparar um derivado de nmentanocarboxamida úteis como elementos sensoriais nos produtos destinados ao consumidor
JP2018533567A (ja) 2015-10-22 2018-11-15 ザ プロクター アンド ギャンブル カンパニー クロマトグラフィー分離方法
EP3390352A1 (en) 2015-12-18 2018-10-24 The Procter and Gamble Company Synthesis of cyclohexane ester derivatives useful as sensates in consumer products
CA3018598A1 (en) 2016-04-01 2017-10-05 The Procter & Gamble Company Oral care compositions containing gel networks and potassium nitrate
MX2018011990A (es) 2016-04-01 2019-02-13 Procter & Gamble Composiciones para el cuidado bucal que contienen nitrato de potasio y peroxido.
US10758461B2 (en) 2016-04-01 2020-09-01 The Procter & Gamble Company Oral care compositions containing a gel network phase and potassium nitrate
CN117643556A (zh) 2016-04-01 2024-03-05 宝洁公司 含有凝胶网络相的口腔护理组合物
EP3435965B1 (en) 2016-04-01 2020-07-29 The Procter and Gamble Company Oral care compositions with an effective flavor display
US20170334082A1 (en) 2016-05-18 2017-11-23 The Gillette Company Llc Skin Engaging Member Comprising Ethylene Vinyl Acetate
US10745865B2 (en) 2016-10-25 2020-08-18 The Procter & Gamble Company Creped fibrous structures
CA3036897C (en) 2016-10-25 2021-11-16 The Procter & Gamble Company Fibrous structures
US20180117780A1 (en) 2016-11-03 2018-05-03 The Gillette Company Llc Skin engaging member comprising ethylene vinyl acetate
WO2018094124A1 (en) 2016-11-17 2018-05-24 The Gillette Company Llc Skin engaging member comprising ethylene vinyl acetate and a fragrance
EP3577215A4 (en) * 2017-02-03 2020-12-30 The Johns Hopkins University USE OF MINI-CANCERS FOR PERSONALIZED ANTI-CANCER DRUG PROTOCOLS
AU2018425680B2 (en) 2018-05-28 2021-12-23 The Procter & Gamble Company Oral care composition with improved deposition efficacy of a cooling sensate agent in the oral cavity
KR102132713B1 (ko) 2018-12-04 2020-07-13 주식회사 오스테온 모발 또는 두피 상태 개선용 조성물
GB201908219D0 (en) * 2019-06-10 2019-07-24 Axalbion Sa Therapeutic use of a compound
AU2021350111B2 (en) 2020-09-28 2025-02-27 The Procter & Gamble Company Oral care composition comprising hops and flavor
JP7592526B2 (ja) * 2021-03-19 2024-12-02 株式会社マンダム Ｔｒｐｖ１活性抑制剤、およびその利用
US12397518B2 (en) * 2021-04-29 2025-08-26 Coopervision International Limited WS12-releasing contact lens
EP4337157A1 (en) 2021-05-11 2024-03-20 The Procter & Gamble Company Oral care compositions comprising block copolymer

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4136163A (en) * 1971-02-04 1979-01-23 Wilkinson Sword Limited P-menthane carboxamides having a physiological cooling effect
PH10359A (en) * 1971-02-04 1977-01-05 Wilkinson Sword Ltd N-substituted-p-methane-3-carboxamides having physiological cooling activity and compositions containing them
US4178459A (en) * 1971-02-04 1979-12-11 Wilkinson Sword Limited N-Substituted paramenthane carboxamides
GB1351761A (en) * 1971-02-04 1974-05-01 Wilkinson Sword Ltd Substituted p-menthane carboxamides and compositions containing them
US4150052A (en) * 1971-02-04 1979-04-17 Wilkinson Sword Limited N-substituted paramenthane carboxamides
US3889804A (en) * 1973-03-14 1975-06-17 Gorham Int Inc Disposable towel
JP2978043B2 (ja) * 1993-09-16 1999-11-15 高砂香料工業株式会社 （２ｓ）−３−｛（１ｒ，２ｓ，５ｒ）−［ ５−メチル−２−（１−メチルエチル）シクロヘキシル ］オキシ｝−１，２−プロパンジオール，その製造方法および用途
US7189760B2 (en) * 2004-04-02 2007-03-13 Millennium Specialty Chemicals Physiological cooling compositions containing highly purified ethyl ester of N-[[5-methyl-2-(1-methylethyl) cyclohexyl] carbonyl]glycine
US20080227857A1 (en) * 2005-03-29 2008-09-18 Edward Tak Wei N-Alkylcarbonyl-Amino Acid Ester and N-Alkylcarbonyl-Amino Lactone Compounds and Their Use

Also Published As

Publication number Publication date
BRPI0609784B1 (pt) 2020-07-07
WO2006103401A2 (en) 2006-10-05
BRPI0609784C1 (pt) 2021-05-25
CY1109420T1 (el) 2014-08-13
CN101184725B (zh) 2012-03-21
DK1871738T3 (da) 2009-09-21
US20110152366A1 (en) 2011-06-23
US20110082204A1 (en) 2011-04-07
PL1871738T3 (pl) 2009-12-31
JP2011068656A (ja) 2011-04-07
WO2006103401A3 (en) 2007-03-08
EP2161252A1 (en) 2010-03-10
DE602006007831D1 (de) 2009-08-27
CN101184725A (zh) 2008-05-21
MX2007011831A (es) 2007-11-21
BRPI0609784B8 (pt) 2020-07-21
SI1871738T1 (sl) 2009-12-31
KR20070116133A (ko) 2007-12-06
ES2328847T3 (es) 2009-11-18
IL186297A0 (en) 2008-01-20
BRPI0609784A2 (pt) 2010-04-27
CA2602075A1 (en) 2006-10-05
EP1871738B1 (en) 2009-07-15
PT1871738E (pt) 2009-09-11
US8853267B2 (en) 2014-10-07
AU2006228280A1 (en) 2006-10-05
EP1871738A2 (en) 2008-01-02
BRPI0609784A8 (pt) 2017-07-11
AU2006228280B2 (en) 2012-08-30
HK1106761A1 (en) 2008-03-20
JP2008538115A (ja) 2008-10-09
CA2602075C (en) 2014-04-29

Similar Documents

Publication Publication Date Title
IL186297A0 (en) N-alkylcarbonyl-amino acid ester and n-alkylcarbonyl-amino lactone compounds and their use
IL190955A0 (en) Dicarboxylic acid derivatives and their use
IL191287A0 (en) Atorvastatin formulation
IL223477A (en) Pharmaceutical preparation containing modified enzyme uricase
IL186042A0 (en) Benzoic acid ester compounds, compositions, uses and methods related thereto
IL190953A0 (en) Cyclopropylacetic acid derivatives and use thereof
IL185895A0 (en) Pyrimidine carboxylic acid derivatives and use thereof
ZA200803555B (en) Manufacture of esters
GB0512940D0 (en) Compounds and their use
IL181330A0 (en) Thiazolo-naphthyl acids
ZA200804239B (en) Novel unsaturated fatty hydroxy acid derivatives and the dermocosmetologic use thereof
ZA200702801B (en) Pharmaceutical composition comprising temozolomide ester
EP1958612A4 (en) TREHALOSE FATTY ACID ESTER COMPOSITION
GB0520743D0 (en) Compounds and their use
ZA200609727B (en) Carbonylation of ester
ZA200800348B (en) Derivatives of seleno-amino acids
IL194906A0 (en) Triphenylmethylphosphonate ester derivatives and pharmaceutical compositions containing the same
GB2428678B (en) Glyceride compounds and uses thereof
GB0410603D0 (en) Ester synthesis
TWI370812B (en) Ester compound and its use
EP1803452A4 (en) ESTER DERIVATIVE AND ITS PHARMACEUTICAL USE THEREOF
GB0421012D0 (en) Ester synthesis
ZA200702597B (en) Ester derivative and pharmaceutical use thereof
AP2006003847A0 (en) Benzhimidazolone carboxylic acid derivatives
GB0428060D0 (en) Ester synthesis